APOA1 and atherosclerosis: A number of apoA-I mimetic peptides have been developed over the years and several of them, variants of 4F [5], [6], [25], [26], [28], [29], 3F [27], 6F [30], ATI-5261 [8], mR18L [36] and 5A [7], have been tested in animal models of atherosclerosis.